Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes

被引：58
|
作者：
Nazha, A. [1 ]
Al-Issa, K. [1 ]
Hamilton, B. K. [1 ]
Radivoyevitch, T. [2 ]
Gerds, A. T. [1 ]
Mukherjee, S. [1 ]
Adema, V. [2 ]
Zarzour, A. [1 ]
Abuhadra, N. [1 ]
Patel, B. J. [1 ]
Hirsch, C. M. [2 ]
Advani, A. [1 ]
Przychodzen, B. [2 ]
Carraway, H. E. [1 ]
Maciejewski, J. P. [2 ]
Sekeres, M. A. [1 ]
机构：
[1] Cleveland Clin, Taussig Canc Inst, Leukemia Program, Dept Hematol & Oncol, Cleveland, OH 44106 USA
[2] Cleveland Clin, Taussig Canc Inst, Dept Translat Hematol & Oncol Res, Cleveland, OH 44106 USA
来源：
LEUKEMIA | 2017年 / 31卷 / 12期
关键词：
SCORING SYSTEM; MUTATIONS;
D O I：
10.1038/leu.2017.266
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2848 / 2850
页数：3
相关论文
共 19 条
  • [1] (In)convenience of adding age and comorbidities to prognostic models in myelodysplastic syndromes
    Calvo, Xavier
    Florensa, Lourdes
    Arenillas, Leonor
    LEUKEMIA, 2018, 32 (05) : 1264 - 1266
  • [2] Incorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes
    Nazha, A.
    Narkhede, M.
    Radivoyevitch, T.
    Seastone, D. J.
    Patel, B. J.
    Gerds, A. T.
    Mukherjee, S.
    Kalaycio, M.
    Advani, A.
    Przychodzen, B.
    Carraway, H. E.
    Maciejewski, J. P.
    Sekeres, M. A.
    LEUKEMIA, 2016, 30 (11) : 2214 - 2220
  • [3] Mutation status and burden can improve prognostic prediction of patients with lower-risk myelodysplastic syndromes
    Jiang, Lingxu
    Luo, Yingwan
    Zhu, Shuanghong
    Wang, Lu
    Ma, Liya
    Zhang, Hua
    Shen, Chuying
    Yang, Wenli
    Ren, Yanling
    Zhou, Xinping
    Mei, Chen
    Ye, Li
    Xu, Weilai
    Yang, Haiyang
    Lu, Chenxi
    Jin, Jie
    Tong, Hongyan
    CANCER SCIENCE, 2020, 111 (02) : 580 - 591
  • [4] Validation of the Molecular International Prognostic Scoring System in patients with myelodysplastic syndromes
    Kewan, Tariq
    Bahaj, Waled
    Durmaz, Arda
    Aly, Mai
    Ogbue, Olisaemeka D.
    Carraway, Hetty E.
    Sekeres, Mikkael A.
    Visconte, Valeria
    Gurnari, Carmelo
    Maciejewski, Jaroslaw P.
    BLOOD, 2023, 141 (14) : 1768 - 1772
  • [5] Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients
    He, Rong
    Chiou, Jonathan
    Chiou, Allison
    Chen, Dong
    Chen, Constance P.
    Spethman, Caroline
    Bessonen, Kurt R.
    Oliveira, Jennifer L.
    Nguyen, Phuong L.
    Reichard, Kaaren K.
    Hoyer, James D.
    Althoff, Simon D.
    Roh, Dana J.
    Miller, Mechelle A.
    Yuan, Ji
    Olteanu, Horatiu
    Begna, Kebede
    Tefferi, Ayalew
    Alkhateeb, Hassan
    Patnaik, Mrinal M.
    Litzow, Mark R.
    Al-Kali, Aref
    Viswanatha, David S.
    BLOOD CANCER JOURNAL, 2022, 12 (01)
  • [6] Validation and improvement of the molecular international prognostic scoring system in Chinese patients with myelodysplastic syndromes
    Huang, Nanfang
    Song, Yang
    Wu, Lingyun
    He, Qi
    Zhang, Zheng
    Guo, Juan
    Xu, Feng
    Chang, Chunkang
    Li, Xiao
    ANNALS OF HEMATOLOGY, 2025, 104 (01) : 193 - 206
  • [7] The efficacy of current prognostic models in predicting outcome of patients with myelodysplastic syndromes at the time of hypomethylating agent failure
    Nazha, Aziz
    Komrokji, Rami S.
    Garcia-Manero, Guillermo
    Barnard, John
    Roboz, Gail J.
    Steensma, David P.
    DeZern, Amy E.
    Zell, Katrina
    Zimmerman, Cassie
    Al Ali, Najla
    Jabbour, Elias
    Greenberg, Molly D.
    Kantarjian, Hagop M.
    Maciejewski, Jaroslaw P.
    List, Alan F.
    Sekeres, Mikkael A.
    HAEMATOLOGICA, 2016, 101 (06) : E224 - E227
  • [8] Investigation of 305 patients with myelodysplastic syndromes and 20q deletion for associated cytogenetic and molecular genetic lesions and their prognostic impact
    Bacher, Ulrike
    Haferlach, Torsten
    Schnittger, Susanne
    Zenger, Melanie
    Meggendorfer, Manja
    Jeromin, Sabine
    Roller, Andreas
    Grossmann, Vera
    Krauth, Maria-Theresa
    Alpermann, Tamara
    Kern, Wolfgang
    Haferlach, Claudia
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 164 (06) : 822 - 833
  • [9] Comparison of five diagnostic flow cytometry scores in patients with myelodysplastic syndromes: Diagnostic power and prognostic impact
    Oelschlaegel, Uta
    Oelschlaeger, Lorenz
    von Bonin, Malte
    Kramer, Michael
    Sockel, Katja
    Mohr, Brigitte
    Wagenfuehr, Lisa
    Kroschinsky, Frank
    Bornhaeuser, Martin
    Platzbecker, Uwe
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2023, 104 (02) : 141 - 150
  • [10] Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification
    Lee, Wan-Hsuan
    Tsai, Ming-Tao
    Tsai, Cheng-Hong
    Tien, Feng-Ming
    Lo, Min-Yen
    Tseng, Mei-Hsuan
    Kuo, Yuan-Yeh
    Liu, Ming-Chih
    Yang, Yi-Tsung
    Chen, Jui-Che
    Tang, Jih-Luh
    Sun, Hsun-, I
    Chuang, Yi-Kuang
    Lin, Liang-In
    Chou, Wen-Chien
    Lin, Chien-Chin
    Hou, Hsin-An
    Tien, Hwei-Fang
    BLOOD CANCER JOURNAL, 2023, 13 (01)
12